Brookwood Pharmaceuticals , Inc.

Brookwood Pharmaceuticals, Inc. is focused on drug delivery, clinical trial manufacturing and biomaterials. Brookwood has a wide-range of delivery technologies particularly for long-acting parenterals such as injectable microparticles and injectable solid implants to deliver small molecules, peptides, proteins, and nucleic acids. Partnered programs range from feasibility studies, product development and optimization, process scale up, clinical trial manufacturing of drug-delivery formulations, such as liposomes, microparticles and other long acting parenterals. Lakeshore Biomaterials, a division of Brookwood Pharmaceuticals manufactures poly(lactide-co-glycolide) and other biomaterials. Brookwood Pharmaceuticals is a SurModics company.